Cargando…
A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies
INTRODUCTION: Tumor lysis syndrome (TLS) is a metabolic derangement that results from rapid destruction of cells. It happens frequently in cancers receiving chemotherapy, particularly hematological malignancies. It can lead to death in severe cases. Tumor lysis syndrome that leads to acute renal fai...
Autores principales: | ELJack, Ammar, El Abdallah, Mohamad, Al-Banaa, Kadhim, Chaudhry, Kashif, Musa, Faisal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545775/ https://www.ncbi.nlm.nih.gov/pubmed/31236296 http://dx.doi.org/10.1155/2019/3740547 |
Ejemplares similares
-
Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report
por: Al-Banaa, Kadhim, et al.
Publicado: (2019) -
Tumor Lysis Syndrome in Patients with Hematological Malignancies
por: Belay, Yohannes, et al.
Publicado: (2017) -
Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome
por: Ito, Shoko, et al.
Publicado: (2022) -
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
por: McBride, Ali, et al.
Publicado: (2012) -
Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series
por: Kollathodi, Shehla Basheer, et al.
Publicado: (2018)